Helomics Overview
- Year Founded
-
1995
- Status
-
Acquired/Merged
- Employees
-
140
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$1.5M
Helomics General Information
Description
Provider of integrated clinical contract research and personalized medicine services intended to improve the standard of care for patients. The company's services offer advanced clinical laboratory diagnostic tests as well as scientific and non-scientific product enhancement services to provide customized and differentiated technologies to its clients in the pharmaceutical, diagnostic, biotechnology, and research industries for their specific project needs, enabling patients to get personalized treatments and diagnostic technologies for their diseases.
Contact Information
Website
www.helomics.comCorporate Office
- 91 43rd Street
- Suite 110
- Pittsburgh, PA 15201
- United States
Corporate Office
- 91 43rd Street
- Suite 110
- Pittsburgh, PA 15201
- United States
Helomics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 13. Merger/Acquisition | 16-Sep-2026 | $1.5M | Completed | Generating Revenue | ||
| 12. Merger/Acquisition | 04-Apr-2019 | Completed | Generating Revenue | |||
| 11. Later Stage VC | 01-Mar-2018 | Completed | Generating Revenue | |||
| 10. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 9. Later Stage VC (Series A) | 12-Nov-2014 | Completed | Generating Revenue | |||
| 8. Later Stage VC (Series A) | 07-Aug-2013 | Completed | Generating Revenue | |||
| 7. Mezzanine | 31-Dec-2010 | Completed | Generating Revenue | |||
| 6. Merger/Acquisition | 04-Mar-2008 | Cancelled | Generating Revenue | |||
| 5. IPO | 06-Dec-2007 | $80.5M | Cancelled | Generating Revenue | ||
| 4. Later Stage VC (Series B) | 22-Feb-2006 | $20.2M | $82.8M | Completed | Generating Revenue |
Helomics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
Helomics Comparisons
Industry
Financing
Details
Helomics Competitors (39)
One of Helomics’s 39 competitors is Gradalis, a Private Equity-Backed company based in Carrollton, TX.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Gradalis | Private Equity-Backed | Carrollton, TX | ||||
| etherna | Formerly VC-backed | Niel, Belgium | ||||
| Ability Biotherapeutics | Venture Capital-Backed | Montreal, Canada | ||||
| Alturas Analytics | Corporation | Moscow, ID | ||||
| EvolveImmune Therapeutics | Venture Capital-Backed | Branford, CT |
Helomics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Helomics Patents
Helomics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20180052168-A1 | Ex vivo liquid biopsy | Inactive | 11-Mar-2016 | ||
| US-20200043575-A1 | Electronic system with a data engine for processing retrieved data in displaying graphical data for a graphical user interface on an external input/output device | Inactive | 14-Feb-2011 | ||
| US-20140052428-A1 | Learning to predict effects of compounds on targets | Inactive | 14-Feb-2011 | ||
| US-20120077687-A1 | Prognostic and predictive gene signature for non-small cell lung cancer and adjuvant chemotherapy | Inactive | 18-Jun-2010 | ||
| US-20140072999-A1 | Methods of simulating chemotherapy for a patient | Inactive | 03-Nov-2008 | G16H50/50 |
Helomics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Helomics Former Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Adams Capital Management | Venture Capital | Minority | ||
| Axe Compute | Corporation | Majority | ||
| Birchmere Ventures | Venture Capital | Minority | ||
| BoldCap | Venture Capital | Minority | ||
| Draper Fisher Jurvetson Management | Venture Capital | Minority |
Helomics Investments (1)
Helomics’s most recent deal was a Joint Venture with Precision Oncology Insights platform. The deal was made on 09-Aug-2018.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Precision Oncology Insights platform | 09-Aug-2018 | Joint Venture | Decision/Risk Analysis |
Helomics FAQs
-
When was Helomics founded?
Helomics was founded in 1995.
-
Where is Helomics headquartered?
Helomics is headquartered in Pittsburgh, PA.
-
What is the size of Helomics?
Helomics has 140 total employees.
-
What industry is Helomics in?
Helomics’s primary industry is Biotechnology.
-
Is Helomics a private or public company?
Helomics is a Private company.
-
What is the current valuation of Helomics?
The current valuation of Helomics is .
-
What is Helomics’s current revenue?
The current revenue for Helomics is .
-
How much funding has Helomics raised over time?
Helomics has raised $174M.
-
Who are Helomics’s investors?
Adams Capital Management, Axe Compute, Birchmere Ventures, BoldCap, and Draper Fisher Jurvetson Management are 5 of 14 investors who have invested in Helomics.
-
Who are Helomics’s competitors?
Gradalis, etherna, Ability Biotherapeutics, Alturas Analytics, and EvolveImmune Therapeutics are some of the 39 competitors of Helomics.
-
When was Helomics acquired?
Helomics was acquired on 16-Sep-2026.
-
Who acquired Helomics?
Helomics was acquired by DataMEDS AI.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
